Deal overview
| Target | REGENERON PHARMACEUTICALS INC |
|---|---|
| Bidder | INVESTORS |
| Price | £80.00 Full version or £25.00 Light version |
| Publication Date | May 25, 2020 |
| Abstract | On 25 May 2020, the quoted French pharmaceutical company Sanofi SA ("Sanofi") announced its intent to sell its equity investment in Regeneron Pharmaceuticals Inc ("Regeneron"), a US-listed biotechnology company, through a registered public offering and related share repurchase by Regeneron itself. The registered offering would have no impact on the ongoing collaboration ... |
| Number of pages (Full version) | 8 |
| Number of pages (Light version) | 2 |
| Format | Adobe Acrobat (Download Acrobat Reader) |
| Free Sample | Click Here to Download |
Purchase this report
Buy and download this report in a fast a safe way using our secure payment system. We accept all major credit cards.
©2024 M&A Monitor Limited
